SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-009438
Filing Date
2021-03-03
Accepted
2021-03-03 17:28:43
Documents
2
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1610
2 EX-24 DOCUMENT attachment1.htm EX-24 3881
  Complete submission text file 0000899243-21-009438.txt   6809
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043
Business Address
Mokari Atabak (Reporting) CIK: 0001678419 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 21710671